Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 223

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 223
---
 claims against us, in accordance with the dispute resolution provisions contained in our amended and restated bylaws, and
you do not, in a judgment prevail, you will be obligated to reimburse us for all reasonable costs and expenses incurred in connection
with such claim, including, but not limited to, reasonable attorney’s fees and expenses and costs of appeal, if any. Additionally,
this provision in Section 7.4 of our amended and restated bylaws could discourage shareholder lawsuits that might otherwise benefit the
Company and its shareholders.

THE
FEE SHIFTING PROVISION CONTAINED IN THE AMENDED AND RESTATED BYLAWS IS NOT INTENDED TO BE DEEMED A WAIVER BY ANY HOLDER OF COMMON STOCK
OF THE COMPANY’S COMPLIANCE WITH THE U.S. FEDERAL SECURITIES LAWS AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER. THE FEE
SHIFTING PROVISION CONTAINED IN THE AMENDED AND RESTATED BYLAWS DO NOT APPLY TO CLAIMS BROUGHT UNDER THE EXCHANGE ACT AND SECURITIES ACT.

Our Transfer Agent

The transfer agent and registrar
for our common stock is Equiniti Trust Company. The transfer agent and registrar’s address is 1110 Centre Pointe Curve, Suite 101,
Mendota Heights, Minnesota 55120. The transfer agent’s telephone (800) 401-1957.

<div align='center'>RESTRICTIONS ON RESALE OF SECURITIES</div>

Rule 144

Pursuant to Rule 144 under
the Securities Act (“Rule 144”), a person who has beneficially owned restricted shares of our common stock for at least six
months would be entitled to sell their securities; provided,that (i) such person is not deemed to have been an affiliate
of the Company at the time of, or at any time during the three months preceding, a sale and (ii) the Company is subject to the Exchange
Act periodic reporting requirements for at least three months before the sale and has filed all required reports under Section 13 or 15(d)
of the Exchange Act during the 12 months (or such shorter period as it was required to file reports) preceding the sale.

| 127 |

Persons who have beneficially
owned restricted shares of common stock for at least six months but who are affiliates of the Company at the time of, or at any time during
the three months preceding, a sale would be subject to additional restrictions, by which such person would